Organogenesis Holdings Inc (ORGO) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ... [Yahoo! Finance]
Organogenesis Holdings Inc. - Class A (ORGO)
Last organogenesis holdings inc. - class a earnings: 3/9 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Net Product Revenue: $225.1 million, up 78% year over year and up 50% sequentially. Advanced Wound Care Revenue: $217.2 million, up 83% year over year. Surgical and Sports Medicine Revenue: $7.9 million, down 2% year over year. Gross Profit: $175.2 million, 78% of net product revenue, up from 75% last year. Operating Expenses: $162.3 million, up 39% from last year. Operating Income: $63.3 million, up 519% from last year. GAAP Net Income: $43.7 million, up from $7.7 million last year. Adjusted Net Income: $52.9 million, up from $8.8 million last year. Adjusted EBITDA: $84.2 million, 37% of total revenue, up from $18.2 million last year. Cash and Equivalents: $94.3 million as of December 30, 2025. 2026 Revenue Outlook: Expected decline of 25% to 38% year over year. Warning! GuruFocus has detected 3 Warning Signs with ORGO. Is ORGO fairly valued? Test your thesis with our free DCF calculator. Release Date: February 26,
Show less
Read more
Impact Snapshot
Event Time:
ORGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORGO alerts
High impacting Organogenesis Holdings Inc. - Class A news events
Weekly update
A roundup of the hottest topics
ORGO
News
- Organogenesis (ORGO) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c)".MarketBeat
- Organogenesis (ORGO) had its price target lowered by BTIG Research from $9.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record RevenueGlobeNewswire
- Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]Yahoo! Finance
ORGO
Earnings
- 5/8/25 - Miss
ORGO
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4/A
- 3/3/26 - Form 4/A
- ORGO's page on the SEC website